Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors.
Closed to Accrual with Ongoing Follow-up
Defintions of terms and FAQ about clinical trials.
Syma Iqbal, M.D.
Other Trial Staff:
Marile Garcia, Coordinator, Noureddine Miloud, D.M., Rabia Rehman, Coordinator
to see study documents.
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.